vs
MANNKIND CORP（MNKD）与RESOURCES CONNECTION, INC.（RGP）财务数据对比。点击上方公司名可切换其他公司
RESOURCES CONNECTION, INC.的季度营收约是MANNKIND CORP的1.1倍（$117.7M vs $112.0M），RESOURCES CONNECTION, INC.净利率更高（-10.8% vs -14.2%，领先3.5%），MANNKIND CORP同比增速更快（45.8% vs -19.2%），RESOURCES CONNECTION, INC.自由现金流更多（$15.6M vs $-10.0M），过去两年MANNKIND CORP的营收复合增速更高（30.0% vs -11.8%）
曼凯德公司是一家生物制药企业，成立于1991年2月，总部位于美国康涅狄格州丹伯里，专注于糖尿病、肺动脉高压等疾病治疗药物的研发、生产及商业化推广，致力于为相关患者提供创新的治疗方案。
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
MNKD vs RGP — 直观对比
营收规模更大
RGP
是对方的1.1倍
$112.0M
营收增速更快
MNKD
高出65.0%
-19.2%
净利率更高
RGP
高出3.5%
-14.2%
自由现金流更多
RGP
多$25.5M
$-10.0M
两年增速更快
MNKD
近两年复合增速
-11.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $112.0M | $117.7M |
| 净利润 | $-15.9M | $-12.7M |
| 毛利率 | 87.6% | 37.1% |
| 营业利润率 | -6.9% | -10.3% |
| 净利率 | -14.2% | -10.8% |
| 营收同比 | 45.8% | -19.2% |
| 净利润同比 | -314.9% | 81.6% |
| 每股收益（稀释后） | $-0.05 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MNKDRGP
| Q4 25 | $112.0M | $117.7M | ||
| Q3 25 | $82.1M | $120.2M | ||
| Q2 25 | $76.5M | $139.3M | ||
| Q1 25 | $78.4M | $129.4M | ||
| Q4 24 | $76.8M | $145.6M | ||
| Q3 24 | $70.1M | $136.9M | ||
| Q2 24 | $72.4M | $148.2M | ||
| Q1 24 | $66.3M | $151.3M |
净利润MNKDRGP
| Q4 25 | $-15.9M | $-12.7M | ||
| Q3 25 | $8.0M | $-2.4M | ||
| Q2 25 | $668.0K | $-73.3M | ||
| Q1 25 | $13.2M | $-44.1M | ||
| Q4 24 | $7.4M | $-68.7M | ||
| Q3 24 | $11.6M | $-5.7M | ||
| Q2 24 | $-2.0M | $10.5M | ||
| Q1 24 | $10.6M | $2.5M |
毛利率MNKDRGP
| Q4 25 | 87.6% | 37.1% | ||
| Q3 25 | 94.5% | 39.5% | ||
| Q2 25 | 94.0% | 40.2% | ||
| Q1 25 | 95.2% | 35.1% | ||
| Q4 24 | 93.7% | 38.5% | ||
| Q3 24 | 95.4% | 36.5% | ||
| Q2 24 | 92.3% | 40.2% | ||
| Q1 24 | 94.2% | 37.0% |
营业利润率MNKDRGP
| Q4 25 | -6.9% | -10.3% | ||
| Q3 25 | 23.0% | -1.7% | ||
| Q2 25 | 6.9% | -47.0% | ||
| Q1 25 | 28.5% | -38.4% | ||
| Q4 24 | 34.5% | -52.7% | ||
| Q3 24 | 18.2% | -3.5% | ||
| Q2 24 | 22.9% | 7.6% | ||
| Q1 24 | 25.2% | 2.8% |
净利率MNKDRGP
| Q4 25 | -14.2% | -10.8% | ||
| Q3 25 | 9.7% | -2.0% | ||
| Q2 25 | 0.9% | -52.6% | ||
| Q1 25 | 16.8% | -34.0% | ||
| Q4 24 | 9.7% | -47.2% | ||
| Q3 24 | 16.5% | -4.2% | ||
| Q2 24 | -2.8% | 7.1% | ||
| Q1 24 | 16.0% | 1.7% |
每股收益（稀释后）MNKDRGP
| Q4 25 | $-0.05 | $-0.38 | ||
| Q3 25 | $0.03 | $-0.07 | ||
| Q2 25 | $0.00 | $-2.21 | ||
| Q1 25 | $0.04 | $-1.34 | ||
| Q4 24 | $0.03 | $-2.08 | ||
| Q3 24 | $0.04 | $-0.17 | ||
| Q2 24 | $-0.01 | $0.31 | ||
| Q1 24 | $0.04 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $171.3M | $89.8M |
| 总债务越低越好 | $354.6M | — |
| 股东权益账面价值 | $-51.0M | $194.6M |
| 总资产 | $792.2M | $289.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MNKDRGP
| Q4 25 | $171.3M | $89.8M | ||
| Q3 25 | $260.0M | $77.5M | ||
| Q2 25 | $179.0M | $86.1M | ||
| Q1 25 | $181.5M | $72.5M | ||
| Q4 24 | $197.3M | $78.2M | ||
| Q3 24 | $251.6M | $89.6M | ||
| Q2 24 | $247.8M | $108.9M | ||
| Q1 24 | $300.7M | $113.8M |
总债务MNKDRGP
| Q4 25 | $354.6M | — | ||
| Q3 25 | $109.7M | — | ||
| Q2 25 | $36.2M | — | ||
| Q1 25 | $36.1M | — | ||
| Q4 24 | $36.1M | — | ||
| Q3 24 | $227.9M | — | ||
| Q2 24 | $227.6M | — | ||
| Q1 24 | $264.1M | — |
股东权益MNKDRGP
| Q4 25 | $-51.0M | $194.6M | ||
| Q3 25 | $-44.6M | $206.4M | ||
| Q2 25 | $-55.0M | $207.1M | ||
| Q1 25 | $-58.6M | $277.8M | ||
| Q4 24 | $-78.8M | $325.7M | ||
| Q3 24 | $-209.9M | $407.2M | ||
| Q2 24 | $-225.8M | $418.8M | ||
| Q1 24 | $-230.0M | $414.9M |
总资产MNKDRGP
| Q4 25 | $792.2M | $289.3M | ||
| Q3 25 | $494.6M | $287.2M | ||
| Q2 25 | $411.7M | $304.7M | ||
| Q1 25 | $410.1M | $375.6M | ||
| Q4 24 | $393.8M | $424.9M | ||
| Q3 24 | $464.2M | $512.9M | ||
| Q2 24 | $443.8M | $510.9M | ||
| Q1 24 | $480.9M | $523.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.0M | $15.9M |
| 自由现金流经营现金流 - 资本支出 | $-10.0M | $15.6M |
| 自由现金流率自由现金流/营收 | -8.9% | 13.2% |
| 资本支出强度资本支出/营收 | 1.8% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $13.7M | $24.3M |
8季度趋势，按日历期对齐
经营现金流MNKDRGP
| Q4 25 | $-8.0M | $15.9M | ||
| Q3 25 | $23.6M | $-7.8M | ||
| Q2 25 | $8.9M | $16.8M | ||
| Q1 25 | $-6.4M | $659.0K | ||
| Q4 24 | $22.6M | $1.8M | ||
| Q3 24 | $9.3M | $-309.0K | ||
| Q2 24 | $3.8M | $3.2M | ||
| Q1 24 | $6.7M | $20.5M |
自由现金流MNKDRGP
| Q4 25 | $-10.0M | $15.6M | ||
| Q3 25 | $22.5M | $-8.0M | ||
| Q2 25 | $7.8M | $16.5M | ||
| Q1 25 | $-6.7M | $238.0K | ||
| Q4 24 | $19.7M | $61.0K | ||
| Q3 24 | $7.9M | $-575.0K | ||
| Q2 24 | $861.0K | $3.0M | ||
| Q1 24 | $4.3M | $20.4M |
自由现金流率MNKDRGP
| Q4 25 | -8.9% | 13.2% | ||
| Q3 25 | 27.4% | -6.6% | ||
| Q2 25 | 10.2% | 11.8% | ||
| Q1 25 | -8.6% | 0.2% | ||
| Q4 24 | 25.7% | 0.0% | ||
| Q3 24 | 11.3% | -0.4% | ||
| Q2 24 | 1.2% | 2.1% | ||
| Q1 24 | 6.5% | 13.5% |
资本支出强度MNKDRGP
| Q4 25 | 1.8% | 0.3% | ||
| Q3 25 | 1.4% | 0.1% | ||
| Q2 25 | 1.5% | 0.2% | ||
| Q1 25 | 0.4% | 0.3% | ||
| Q4 24 | 3.8% | 1.2% | ||
| Q3 24 | 2.0% | 0.2% | ||
| Q2 24 | 4.1% | 0.1% | ||
| Q1 24 | 3.6% | 0.1% |
现金转化率MNKDRGP
| Q4 25 | — | — | ||
| Q3 25 | 2.96× | — | ||
| Q2 25 | 13.40× | — | ||
| Q1 25 | -0.48× | — | ||
| Q4 24 | 3.05× | — | ||
| Q3 24 | 0.81× | — | ||
| Q2 24 | — | 0.30× | ||
| Q1 24 | 0.63× | 8.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MNKD
| Products | $50.4M | 45% |
| Royalty | $33.6M | 30% |
| Afrezza | $22.9M | 20% |
| V Go | $4.3M | 4% |
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
